The Food and Drug Administration is a government agency responsible for the investigation, evaluation, allocation, and lastly the supervising of food, drugs, cosmetics, medical devices, radiation equipment, and other health related products that the public relies on daily for health and medical necessity. Being the highly innovative and productive society that America is, it goes without saying that consumers are busier than ever and time is a very valuable asset to have in your pocket. Time is money, the old saying goes, well in the case of medical research the smallest fraction of time could mean the discovery of a cure, the saving of ones life, or even the loss. Because time has such high value, the price of time is more expensive than it has ever been. Long gone are the days of “taking time to mull it over” or “stopping to take it all in”, no, now time defines a persons every move.
Companies too, live and breathe by time. A successful company manages time well and has the productivity to exemplify their admiration for time efficiency. In the spectrum of pharmaceuticals, where this research takes place, it has been discovered that the time spent previously developing drugs and devices is out of date and now are the times of fast, swift, quick innovation. The faster a company develops, markets, and distributes a product, the better chance they have at the monopoly of that product. If a drug company creates a new prescription drug for the treatment of Diabetes that no other company has created, a drug that treats a cause specific ailment, then that company will do anything to mass produce the product as to build rapport with consumers and obtain the monopoly for this particular drug therapy.
Public pressure is a fierce competitor and companies strive to stay above it, this pressure leads to short cuts taken by companies, regulation changes by governmental agencies, and a lack of good product production. Consumers see this far too often now. How many times a day does someone hear via television commercial, see by billboard, or hear through radio programs that a prominent law firm is suing the makers of “such and such” because of the products tendency to cause “this and that” all due to the fact that the product was not properly tested and far to quickly pushed to the open market for consumption. That is the power of demand, a group expects more and more, but quality diminishes. Some experts are criticizing the FDA for expediting the approval of certain drugs, like the blood thinner Pradaxa and the multiple sclerosis drug Gilenya, before they were adequately vetted by testing facilities and university studies. U.S. consumers may have been exposed to dangerous drugs in the name of fostering innovation, according to a medical study by Thomas J. Moore and Dr. Curt D. Furberg that was published in the September 5, 2012 edition of the Journal of the American Medical Association, better known as JAMA. According to (Furberg,...